查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1602767

動物疫苗市場：依產品類型 - 2025-2030 年全球預測

Animal Vaccines Market by Product (Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines), Animal Type (Aqua, Companion, Poultry) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年動物疫苗市值為163.9億美元，預計2024年將達到177.5億美元，複合年成長率為8.34%，到2030年將達到287.2億美元。

獸用疫苗市場包括各種為預防和控制家畜、家畜和野生動物疾病而開發的免疫產品。這些疫苗對於保護動物健康、提高農業生產力和減少通用感染疾病向人類的傳播至關重要。應用範圍從寵物的常規疫苗接種到牛、家禽、豬等牲畜的大規模疫苗接種，具體的最終用戶包括獸醫醫院、診所、農場和研究機構。寵物主人數量的增加、動物性食品消費量的增加以及動物健康意識的增強推動了市場的成長。此外，世界對通用感染疾病爆發的日益關注凸顯了嚴格疫苗接種計畫的重要性。重組 DNA 疫苗和奈米顆粒遞送系統等技術進步為創新提供了重要機會。透過投資研發，公司可以利用這些進步，開發出以更少劑量提供更廣泛保護的疫苗。然而，市場開拓面臨許多挑戰，包括嚴格的法律規範、高昂的開發成本以及新興國家的疫苗儲存和分配問題。透過與政府機構合作並利用人工智慧主導的分析來簡化核准流程，可以透過解決這些障礙來提高市場滲透率。還有機會開發針對多種病原體提供交叉保護的疫苗，並探索口服和鼻腔給藥方法以提高依從性和給藥便利性。我們對個人化獸醫醫學和資料分析的關注使我們能夠根據當地疾病流行情況和動物人口統計數據提供量身定做的疫苗接種計劃，從而推動市場成長。為了保持競爭力，公司應優先考慮創新、策略聯盟和拓展新興市場，以及開展教育工作以提高人們對疫苗接種益處的認知。總之，在技術進步和對動物健康日益關注的推動下，獸用疫苗市場有望持續成長，但要充分發揮其潛力，還需要克服各種障礙。

主要市場統計
基準年[2023] 163.9億美元
預測年份 [2024] 177.5億美元
預測年份 [2030] 287.2億美元
複合年成長率（%） 8.34%

市場動態：揭示快速發展的獸用疫苗市場的關鍵市場洞察

供需的動態交互作用正在改變動物疫苗市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 牲畜數量增加
    • 由於畜產品商業化，畜牧業增加
    • 通用感染疾病增加
  • 市場限制因素
    • 供應成本相對較高，資本收益低於人用疫苗
  • 市場機會
    • 從活病毒疫苗轉向 DNA 疫苗
    • 疫苗技術不斷進步
  • 市場問題
    • 疫苗的不良反應

波特五力：駕馭動物疫苗市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解獸用疫苗市場的外部影響

外部宏觀環境因素對獸用疫苗市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解動物疫苗市場競爭格局

對獸用疫苗市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：獸用疫苗市場供應商的績效評估

FPNV定位矩陣是評估獸用疫苗市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：規劃動物疫苗市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對動物疫苗市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 牲畜增加
      • 畜牧業發展及畜產品商品化
      • 通用感染疾病發生率增加
    • 抑制因素
      • 供應成本相對較高，資本收益低於人用疫苗
    • 機會
      • 從減毒活疫苗到 DNA 疫苗的過渡
      • 疫苗技術不斷進步
    • 任務
      • 疫苗副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章動物疫苗市場：依產品

  • 介紹
  • 減毒活病毒疫苗
  • DNA疫苗
  • 去活化疫苗
  • 重組疫苗
  • 次單位疫苗

第7章動物疫苗市場：依動物類型

  • 介紹
  • 水生動物
    • 產氣單胞菌
    • 鏈球菌
    • 弧菌
  • 伴同性
    • 狗
      • 狗狗皰疹
      • 犬瘟熱
      • 犬窩咳
      • 萊姆病
      • 細小病毒
      • 狂犬病狗
    • 貓
      • 杯狀病毒
      • 冠狀病毒貓
      • 全白血球減少症
      • 狂犬病貓
      • 鼻氣管炎
  • 家禽
    • 禽流感
    • 傳染性支氣管炎
    • 馬立克氏症
    • 新城疫
    • 沙門氏菌
  • 反芻動物
    • 冠狀病毒反芻動物
    • 大腸桿菌
    • 手足口病 (FMD)
    • 塊狀皮膚病
    • 輪狀病毒

第8章美洲動物疫苗市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太動物疫苗市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲動物疫苗市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Anicon Labor GmbH by SAN Group
  • Biogenesis Bago SA
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma Private limited
  • Ceva Sante Animale
  • China Animal Husbandry Industry Co., Ltd.
  • Dalan Animal Health.
  • Eli Lilly and Company
  • Endovac Animal Health, LLC
  • Heska Corporation
  • Hester Biosciences Limited
  • HIPRA, SA
  • Indian Immunologicals Limited
  • Merck KGaA
  • Neogen Corporation
  • Pfizer Inc.
  • Phibro Animal Health Corporation
  • Sanofi SA
  • Torigen Pharmaceuticals Inc.
  • Vaxxinova GmbH
  • VEROVACCiNES GmbH
  • Vetigenics
  • Vetoquinol SA
  • Virbac, Inc.
  • Zoetis Inc.
Product Code: MRR-ED54C46E8F03

The Animal Vaccines Market was valued at USD 16.39 billion in 2023, expected to reach USD 17.75 billion in 2024, and is projected to grow at a CAGR of 8.34%, to USD 28.72 billion by 2030.

The animal vaccines market encompasses various immunological products developed to prevent and control diseases in domesticated animals, livestock, and wildlife. These vaccines are crucial for safeguarding animal health, improving agricultural productivity, and reducing the transmission of zoonotic diseases to humans. Their applications range from routine immunizations in pets to large-scale inoculations in livestock like cattle, poultry, and pigs, with specific end-users comprising veterinary hospitals, clinics, farms, and research institutions. Market growth is fueled by rising pet ownership, increased consumption of animal-derived food products, and heightened awareness of animal health. Moreover, growing global concerns about zoonotic disease outbreaks have highlighted the significance of rigorous vaccination programs. Technological advancements, such as recombinant DNA vaccines and nanoparticle-based delivery systems, present vast opportunities for innovation. Companies can leverage these advancements by investing in R&D to develop vaccines offering broader protection with fewer doses. However, market expansion faces several challenges, including stringent regulatory frameworks, high development costs, and vaccine storage and distribution issues in developing regions. Addressing these barriers by partnering with government agencies and harnessing AI-driven analytics for streamlined approval processes can enhance market penetration. Opportunities also lie in developing vaccines that provide cross-protection against multiple pathogens, as well as exploring oral and intranasal delivery methods to improve compliance and ease of administration. Focusing on personalized veterinary medicine and data analytics can provide tailored vaccination programs based on regional disease prevalence and animal demographics, fostering market growth. To remain competitive, companies should prioritize technological innovation, strategic alliances, and expansion into emerging markets, coupled with educational initiatives to raise awareness about the benefits of vaccination. In summary, the animal vaccines market is poised for sustained growth, driven by technological advancements and a growing emphasis on animal health, though it must navigate various regulatory and logistical hurdles to maximize potential.

KEY MARKET STATISTICS
Base Year [2023] USD 16.39 billion
Estimated Year [2024] USD 17.75 billion
Forecast Year [2030] USD 28.72 billion
CAGR (%) 8.34%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Vaccines Market

The Animal Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing Livestock Population
    • Rising Animal Husbandry along with Commercialization of Animal Products
    • Increasing Incidences of Zoonotic Diseases
  • Market Restraints
    • Supply End Costs are Relatively High, with Poorer Capital Returns than Human Vaccines
  • Market Opportunities
    • Shift from Live Attenuated Vaccines to DNA Vaccines
    • Continuous Technological Advancements in Vaccines
  • Market Challenges
    • Adverse Impacts of Vaccines

Porter's Five Forces: A Strategic Tool for Navigating the Animal Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Vaccines Market

A detailed market share analysis in the Animal Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Vaccines Market

A strategic analysis of the Animal Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Vaccines Market, highlighting leading vendors and their innovative profiles. These include Anicon Labor GmbH by SAN Group, Biogenesis Bago S.A., Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private limited, Ceva Sante Animale, China Animal Husbandry Industry Co., Ltd., Dalan Animal Health., Eli Lilly and Company, Endovac Animal Health, LLC, Heska Corporation, Hester Biosciences Limited, HIPRA, S.A., Indian Immunologicals Limited, Merck KGaA, Neogen Corporation, Pfizer Inc., Phibro Animal Health Corporation, Sanofi S.A., Torigen Pharmaceuticals Inc., Vaxxinova GmbH, VEROVACCiNES GmbH, Vetigenics, Vetoquinol SA, Virbac, Inc., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Attenuated Live Vaccines, DNA Vaccines, Inactivated Vaccines, Recombinant Vaccines, and Subunit Vaccines.
  • Based on Animal Type, market is studied across Aqua, Companion, Poultry, and Ruminants. The Aqua is further studied across Aeromonas, Streptococcosis, and Vibrio. The Companion is further studied across Canine and Feline. The Canine is further studied across Canine Herpes, Distemper, Kennel Cough, Lyme Disease, Parvovirus, and Rabies Canine. The Feline is further studied across Calicivirus, Coronavirus Feline, Panleukopenia, Rabies Feline, and Rhinotracheitis. The Poultry is further studied across Avian Influenza, Infectious Bronchitis, Marek's Disease, Newcastle Disease, and Salmonella. The Ruminants is further studied across Coronavirus Ruminants, E. Coli, Foot & mouth disease (FMD), Lumpy skin, and Rotavirus.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Livestock Population
      • 5.1.1.2. Rising Animal Husbandry along with Commercialization of Animal Products
      • 5.1.1.3. Increasing Incidences of Zoonotic Diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Supply End Costs are Relatively High, with Poorer Capital Returns than Human Vaccines
    • 5.1.3. Opportunities
      • 5.1.3.1. Shift from Live Attenuated Vaccines to DNA Vaccines
      • 5.1.3.2. Continuous Technological Advancements in Vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse Impacts of Vaccines
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Animal Vaccines Market, by Product

  • 6.1. Introduction
  • 6.2. Attenuated Live Vaccines
  • 6.3. DNA Vaccines
  • 6.4. Inactivated Vaccines
  • 6.5. Recombinant Vaccines
  • 6.6. Subunit Vaccines

7. Animal Vaccines Market, by Animal Type

  • 7.1. Introduction
  • 7.2. Aqua
    • 7.2.1. Aeromonas
    • 7.2.2. Streptococcosis
    • 7.2.3. Vibrio
  • 7.3. Companion
    • 7.3.1. Canine
      • 7.3.1.1. Canine Herpes
      • 7.3.1.2. Distemper
      • 7.3.1.3. Kennel Cough
      • 7.3.1.4. Lyme Disease
      • 7.3.1.5. Parvovirus
      • 7.3.1.6. Rabies Canine
    • 7.3.2. Feline
      • 7.3.2.1. Calicivirus
      • 7.3.2.2. Coronavirus Feline
      • 7.3.2.3. Panleukopenia
      • 7.3.2.4. Rabies Feline
      • 7.3.2.5. Rhinotracheitis
  • 7.4. Poultry
    • 7.4.1. Avian Influenza
    • 7.4.2. Infectious Bronchitis
    • 7.4.3. Marek's Disease
    • 7.4.4. Newcastle Disease
    • 7.4.5. Salmonella
  • 7.5. Ruminants
    • 7.5.1. Coronavirus Ruminants
    • 7.5.2. E. Coli
    • 7.5.3. Foot & mouth disease (FMD)
    • 7.5.4. Lumpy skin
    • 7.5.5. Rotavirus

8. Americas Animal Vaccines Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Animal Vaccines Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Animal Vaccines Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anicon Labor GmbH by SAN Group
  • 2. Biogenesis Bago S.A.
  • 3. Boehringer Ingelheim International GmbH
  • 4. Brilliant Bio Pharma Private limited
  • 5. Ceva Sante Animale
  • 6. China Animal Husbandry Industry Co., Ltd.
  • 7. Dalan Animal Health.
  • 8. Eli Lilly and Company
  • 9. Endovac Animal Health, LLC
  • 10. Heska Corporation
  • 11. Hester Biosciences Limited
  • 12. HIPRA, S.A.
  • 13. Indian Immunologicals Limited
  • 14. Merck KGaA
  • 15. Neogen Corporation
  • 16. Pfizer Inc.
  • 17. Phibro Animal Health Corporation
  • 18. Sanofi S.A.
  • 19. Torigen Pharmaceuticals Inc.
  • 20. Vaxxinova GmbH
  • 21. VEROVACCiNES GmbH
  • 22. Vetigenics
  • 23. Vetoquinol SA
  • 24. Virbac, Inc.
  • 25. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. ANIMAL VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. ANIMAL VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANIMAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ANIMAL VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ANIMAL VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANIMAL VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANIMAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANIMAL VACCINES MARKET DYNAMICS
  • TABLE 7. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ATTENUATED LIVE VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AQUA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AEROMONAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL VACCINES MARKET SIZE, BY STREPTOCOCCOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL VACCINES MARKET SIZE, BY VIBRIO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COMPANION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE HERPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL VACCINES MARKET SIZE, BY DISTEMPER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL VACCINES MARKET SIZE, BY KENNEL COUGH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LYME DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PARVOVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES CANINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FELINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CALICIVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS FELINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL VACCINES MARKET SIZE, BY PANLEUKOPENIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RABIES FELINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RHINOTRACHEITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL VACCINES MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL VACCINES MARKET SIZE, BY AVIAN INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL VACCINES MARKET SIZE, BY INFECTIOUS BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL VACCINES MARKET SIZE, BY MAREK'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL VACCINES MARKET SIZE, BY NEWCASTLE DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL VACCINES MARKET SIZE, BY SALMONELLA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL VACCINES MARKET SIZE, BY CORONAVIRUS RUMINANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL VACCINES MARKET SIZE, BY E. COLI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL VACCINES MARKET SIZE, BY FOOT & MOUTH DISEASE (FMD), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL VACCINES MARKET SIZE, BY LUMPY SKIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL VACCINES MARKET SIZE, BY ROTAVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES ANIMAL VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. JAPAN ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 149. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 160. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 165. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 168. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 169. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 170. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 181. TAIWAN ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. TAIWAN ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. TAIWAN ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 184. TAIWAN ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 185. TAIWAN ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 186. TAIWAN ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 187. TAIWAN ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 188. TAIWAN ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 189. THAILAND ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. THAILAND ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. THAILAND ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 192. THAILAND ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 193. THAILAND ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 194. THAILAND ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 195. THAILAND ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 196. THAILAND ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 197. VIETNAM ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. VIETNAM ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. VIETNAM ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 200. VIETNAM ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 201. VIETNAM ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 202. VIETNAM ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 203. VIETNAM ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 204. VIETNAM ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA ANIMAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 214. DENMARK ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. DENMARK ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. DENMARK ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 217. DENMARK ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 218. DENMARK ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 219. DENMARK ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 220. DENMARK ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 221. DENMARK ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 222. EGYPT ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. EGYPT ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. EGYPT ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 225. EGYPT ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 226. EGYPT ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 227. EGYPT ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 228. EGYPT ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 229. EGYPT ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 230. FINLAND ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. FINLAND ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. FINLAND ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 233. FINLAND ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 234. FINLAND ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 235. FINLAND ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 236. FINLAND ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 237. FINLAND ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 238. FRANCE ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 239. FRANCE ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. FRANCE ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 241. FRANCE ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 242. FRANCE ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 243. FRANCE ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 244. FRANCE ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 245. FRANCE ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 246. GERMANY ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. GERMANY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. GERMANY ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 249. GERMANY ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 250. GERMANY ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 251. GERMANY ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 252. GERMANY ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 253. GERMANY ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 254. ISRAEL ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 255. ISRAEL ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. ISRAEL ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 257. ISRAEL ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 258. ISRAEL ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 259. ISRAEL ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 260. ISRAEL ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 261. ISRAEL ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 262. ITALY ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 263. ITALY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. ITALY ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 265. ITALY ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 266. ITALY ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 267. ITALY ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 268. ITALY ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 269. ITALY ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 270. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 274. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 276. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 277. NETHERLANDS ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 278. NIGERIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 279. NIGERIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. NIGERIA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 281. NIGERIA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 282. NIGERIA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 283. NIGERIA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 284. NIGERIA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 285. NIGERIA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 286. NORWAY ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 287. NORWAY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. NORWAY ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 289. NORWAY ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 290. NORWAY ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 291. NORWAY ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 292. NORWAY ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 293. NORWAY ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 294. POLAND ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 295. POLAND ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. POLAND ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 297. POLAND ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 298. POLAND ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 299. POLAND ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 300. POLAND ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 301. POLAND ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 302. QATAR ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 303. QATAR ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. QATAR ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 305. QATAR ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 306. QATAR ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 307. QATAR ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 308. QATAR ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 309. QATAR ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 310. RUSSIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 311. RUSSIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 312. RUSSIA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 313. RUSSIA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 314. RUSSIA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 315. RUSSIA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 316. RUSSIA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 317. RUSSIA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 318. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 319. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 320. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 321. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 322. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 323. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 324. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 325. SAUDI ARABIA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 326. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 327. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 328. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 329. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 330. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 331. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 332. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 333. SOUTH AFRICA ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 334. SPAIN ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 335. SPAIN ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 336. SPAIN ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 337. SPAIN ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 338. SPAIN ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 339. SPAIN ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 340. SPAIN ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 341. SPAIN ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 342. SWEDEN ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 343. SWEDEN ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 344. SWEDEN ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 345. SWEDEN ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 346. SWEDEN ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 347. SWEDEN ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 348. SWEDEN ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 349. SWEDEN ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 350. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 351. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 352. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 353. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 354. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 355. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 356. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 357. SWITZERLAND ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 358. TURKEY ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 359. TURKEY ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 360. TURKEY ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 361. TURKEY ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 362. TURKEY ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 363. TURKEY ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 364. TURKEY ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 365. TURKEY ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 366. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 367. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 368. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 369. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 370. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 371. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
  • TABLE 372. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
  • TABLE 373. UNITED ARAB EMIRATES ANIMAL VACCINES MARKET SIZE, BY RUMINANTS, 2018-2030 (USD MILLION)
  • TABLE 374. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 375. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 376. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY AQUA, 2018-2030 (USD MILLION)
  • TABLE 377. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY COMPANION, 2018-2030 (USD MILLION)
  • TABLE 378. UNITED KINGDOM ANIMAL VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
  • TABLE 379. UNITED KINGDOM ANIMAL V